This study collects cancer-related information from patients with HER2- positive breast cancer to better understand links between patient or tumor characteristics and cancer outcomes in HER2-positive breast cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06603597.
Locations matching your search criteria
United States
Kansas
Kansas City
University of Kansas Cancer CenterStatus: Active
Contact: Priyanka Sharma
Phone: 913-588-6079
PRIMARY OBJECTIVE:
I. To establish a prospective cohort registry of patients with HER2-positive breast cancer.
OUTLINE: This is an observational study.
Patients complete a survey, have their medical records reviewed and undergo blood sample collection on study.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationUniversity of Kansas Cancer Center
Principal InvestigatorPriyanka Sharma
